drugset / Trial / NCT02901587

Study Investigating the Effect of Lu AF35700 on Cardiac Repolarization in Men and Women With Schizophrenia and Schizoaffective Disorder

NCT02901587

Phase 1 Completed 119 enrolled H. Lundbeck A/S
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to investigate the effect of Lu AF35700 on electrical activity in the heart as measured on an electrocardiogram (ECG) in patients with schizophrenia or schizoaffective disorder after 6 weeks of treatment

Timeline

Start
2016-09
Primary completion
2018-04-18
Completion
2018-04-18

Drugs

EvaluationDrugModalityDoseRoute
Subject Lu AF35700 Unknown 10 mg Oral
Subject Lu AF35700 Unknown 30 mg Oral
Subject Quetiapine Small molecule 800 mg Oral